Factors associated with measles vaccination status in children under the age of three years in a post-soviet context: a cross-sectional study using the DHS VII in Armenia.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read Online Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: BioMed Central Country of Publication: England NLM ID: 100968562 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2458 (Electronic) Linking ISSN: 14712458 NLM ISO Abbreviation: BMC Public Health Subsets: MEDLINE
    • Publication Information:
      Original Publication: London : BioMed Central, [2001-
    • Subject Terms:
      Measles*/epidemiology ; Measles*/prevention & control ; Vaccination*; Armenia/epidemiology ; Child ; Child, Preschool ; Cross-Sectional Studies ; Female ; Humans ; Infant ; Measles Vaccine ; Pregnancy ; Vaccination Coverage
    • Abstract:
      Background: The resurgence of measles globally and the increasing number of unvaccinated clusters call for studies exploring factors that influence measles vaccination uptake. Armenia is a middle-income post-Soviet country with an officially high vaccination coverage. However, concerns about vaccine safety are common. The purpose of this study was to measure the prevalence of measles vaccination coverage in children under three years of age and to identify factors that are associated with measles vaccination in Armenia by using nationally representative data.
      Methods: Cross-sectional analysis using self-report data from the most recent Armenian Demographic Health Survey (ADHS VII 2015/16) was conducted. Among 588 eligible women with a last-born child aged 12-35 months, 63 women were excluded due to unknown status of measles vaccination, resulting in 525 women included in the final analyses. We used logistic regression models in order to identify factors associated with vaccination status in the final sample. Complex sample analyses were used to account for the study design.
      Results: In the studied population 79.6% of the children were vaccinated against measles. After adjusting for potential confounders, regression models showed that the increasing age of the child (AOR 1.07, 95% CI: 1.03-1.12), secondary education of the mothers (AOR 3.38, 95% CI: 1.17-9.76) and attendance at postnatal check-up within two months after birth (AOR 2.71, 95% CI: 1.17-6.30) were significantly associated with the vaccination status of the child.
      Conclusions: The measles vaccination coverage among the children was lower than the recommended percentage. The study confirmed the importance of maternal education and attending postnatal care visits. However, the study also showed that there might be potential risks for future measles outbreaks because of delayed vaccinations and a large group of children with an unknown vaccination status.
    • References:
      Indian J Public Health. 2018 Oct-Dec;62(4):253-258. (PMID: 30539885)
      Lancet. 2004 Dec 18-31;364(9452):2204-11. (PMID: 15610807)
      Vaccine. 2017 Feb 7;35(6):951-959. (PMID: 28069359)
      Eur J Clin Microbiol Infect Dis. 2017 Oct;36(10):1899-1906. (PMID: 28550369)
      Lancet. 2003 Sep 27;362(9389):1022-7. (PMID: 14522532)
      Epidemiol Infect. 2015 Feb;143(3):550-60. (PMID: 25600667)
      BMC Public Health. 2014 Mar 06;14:232. (PMID: 24602264)
      BMJ. 2010 Feb 02;340:c696. (PMID: 20124366)
      EBioMedicine. 2016 Oct;12:295-301. (PMID: 27658738)
      J Trauma Stress. 2008 Oct;21(5):440-7. (PMID: 18956450)
      PLoS One. 2018 Nov 28;13(11):e0207209. (PMID: 30485291)
      Eur J Epidemiol. 2004;19(10):979-85. (PMID: 15575358)
      Int J Public Health. 2017 Feb;62(Suppl 1):41-49. (PMID: 27695901)
      BMJ. 2016 Oct 13;355:i5170. (PMID: 27737834)
      BMC Public Health. 2015 Aug 19;15:798. (PMID: 26285702)
      Eur J Clin Microbiol Infect Dis. 2019 Sep;38(9):1719-1729. (PMID: 31289949)
      BMC Public Health. 2012 May 08;12:336. (PMID: 22568861)
      PLoS One. 2014 Apr 21;9(4):e95709. (PMID: 24752178)
      Hum Vaccin Immunother. 2018 Apr 3;14(4):875-880. (PMID: 29252094)
      Vaccine. 2019 Aug 14;37(35):4840-4847. (PMID: 30392764)
      Matern Child Health J. 2015 Aug;19(8):1724-33. (PMID: 25636652)
      BMC Int Health Hum Rights. 2009 Oct 14;9 Suppl 1:S4. (PMID: 19828062)
      Biomed Res Int. 2014;2014:838907. (PMID: 24971352)
      Vaccine. 2017 Apr 4;35(15):1907-1917. (PMID: 28284678)
      J Pediatr. 2016 Oct;177S:S21-S34. (PMID: 27666269)
      Isr J Health Policy Res. 2016 Feb 01;5:2. (PMID: 26839681)
      Vaccine. 2014 Apr 17;32(19):2150-9. (PMID: 24598724)
      BMC Public Health. 2017 Jul 6;17(1):630. (PMID: 28683781)
      Vaccine. 2020 Jun 19;38(30):4671-4678. (PMID: 32448619)
      J Travel Med. 2018 Jan 1;25(1):. (PMID: 30184169)
      Health Policy Plan. 2009 Mar;24(2):101-7. (PMID: 19147699)
      Jpn J Infect Dis. 2018 Sep 21;71(5):354-359. (PMID: 29962485)
      Lancet. 2008 Dec 13;372(9655):2031-46. (PMID: 19070738)
      PLoS One. 2015 Jul 13;10(7):e0132357. (PMID: 26167939)
      Trop Med Infect Dis. 2018 Jun 25;3(3):. (PMID: 30274468)
      Vaccine. 2016 May 23;34(24):2635-43. (PMID: 27109562)
    • Contributed Indexing:
      Keywords: Armenia; Children; MMR; Measles vaccination
    • Accession Number:
      0 (Measles Vaccine)
    • Publication Date:
      Date Created: 20210321 Date Completed: 20210521 Latest Revision: 20240331
    • Publication Date:
      20240331
    • Accession Number:
      PMC7981943
    • Accession Number:
      10.1186/s12889-021-10583-5
    • Accession Number:
      33743623